Item 5. Market for Registrant’s Common Equity
ITEM
5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDERS’ MATTERS, AND ISSUER PURCHASES OF EQUITY SECURITIES
MARKET
INFORMATION AND HOLDERS
The
Company’s Common Stock trades in the over-the-counter market under the symbol RLBY. The high and low sale prices for
2023 and 2022 are set forth below. High and low price is based on the last trading day of the quarter.
First
Quarter
Second
Quarter
Third
Quarter
Fourth
Quarter
2023
High
$
0.0590
$
0.0425
$
0.0549
$
0.0550
Low
$
0.0440
$
0.0425
$
0.0549
$
0.0550
2022
High
$
0.0570
$
0.0580
$
0.0583
$
0.0420
Low
$
0.0560
$
0.0450
$
0.0550
$
0.0420
The
Company paid no cash dividends in 2022 or 2023.
As
of March 18, 2024, the last reported sales price for Company Common Stock was $0.0800 per share.
As
of March 22, 2024, there were 525 holders of record of Company Common Stock.
EQUITY
COMPENSATION PLANS
None
RECENT
SALES OF UNREGISTERED SECURITIES
None
SHARE
REPURCHASES
None
ITEM
6. SELECTED FINANCIAL DATA
The
following tables set forth our summary of consolidated historical financial data. You should read the information set forth below in
conjunction with “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” and
our consolidated historical financial statements and notes thereto included elsewhere in this Annual Report on Form 10-K. The statement
of operations data for the fiscal years ended 2023 and 2022 and the balance sheet data as of December 31, 2023 and 2022 set forth below
are derived from our audited consolidated financial statements included elsewhere in this Annual Report on Form 10-K.
December 31,
Balance Sheet Data:
2023
2022
Working capital
$ 7,913
$ 8,645
Total assets
$ 9,786
$ 13,490
Total outstanding borrowings, net
$ 174
$ 2,619
Total other long-term liabilities
$ -
$ -
Stockholders’ equity
$ 7,931
$ 8,671
25
December 31,
Statement of Operation Data:
2023
2022
Revenues
$ 21,451
$ 25,725
Gross profit
3,039
3,494
Selling, general and administrative expenses
3,788
4,400
Operating loss
(749 )
(906 )
Interest income
25
53
Interest income from related parties
269
232
Interest expense
(92 )
(171 )
Other income (expense)
(179 )
223
Income (loss) before income taxes
(726 )
(569 )
Income tax benefit (expense)
(14 )
(170 )
Net income (loss)
$ (740 )
$ (739 )
December 31,
Net Income (Loss) Per Share:
2023
2022
Net income (loss) per share – basic
$ .00
$ .00
Net income (loss) per share – diluted
$ .00
$ .00
Weighted average shares outstanding – basic
300,000,000
300,000,000
Weighted average shares outstanding – diluted
300,000,000
300,000,000
December
31,
Other
Financial Data:
2023
2022
OIBITDA
(1)
$
57
$
577
(1)
We present OIBITDA as a measure that is not in accordance with generally accepted accounting principles (“non-GAAP”),
in this Annual Report on Form 10-K to provide investors with a supplemental measure of our operating performance. We believe that OIBITDA
is a useful performance measure and is employed by us to facilitate comparisons of our operating performance on a consistent basis from
period-to-period and to provide for a more complete understanding of factors and trends affecting our core business than measures under
generally accepted accounting principles (“GAAP”) can provide alone. Our board and management also use OIBITDA as some of
the primary methods for planning and forecasting overall expected performance and for evaluating on a quarterly and annual basis actual
result against such expectations, and as a performance evaluation metric in determining achievement of certain compensation programs
and plans for our management and organization.
We
define OIBITDA as operational earnings before interest expense, related party interest, income taxes, depreciation and amortization expense,
loss on early extinguishment of debt and related party debt, transaction fees and costs related to our corporate overhead which consist
mainly of costs associated with being a public company. Omitting interest, taxes and the other items provides a financial measure that
facilitates comparisons of our results of operations with those of companies having different capital structures. Since the levels of
indebtedness and tax structures that other companies have are different from ours, we omit these amounts to facilitate investors’
ability to make like comparisons. Similarly, we omit depreciation and amortization because many other companies likely employ a greater
amount of property and intangible assets. We omit corporate or non-operating costs as they are meant to be allocated against a larger
operational base which our business plan outlines. As we grow our operations organically and through M&A activities these corporate
costs are absorbed more equitably, we will use Earnings Before Interest, Taxes, Depreciation and Amortization (“EBITDA”)
as our means of measuring comparable operational performance to other companies in our industry. We also believe that investors, analysts,
and other interested parties view our ability to generate OIBITDA as an important measure of our operating performance and that of other
companies in our industry. OIBITDA should not be considered as an alternative to net income (loss) for the periods indicated as a measure
of our performance.
The
use of OIBITDA has limitations as analytical tools, and you should not consider these performance measures in isolation from, or as an
alternative to, GAAP measures such as net income (loss). OIBITDA is not a measure of liquidity under GAAP or otherwise and is not an
alternative to cash flow from continuing operating activities. Our presentation of OIBITDA should not be construed as an inference that
our future results will be unaffected by the expenses that are excluded from that term or by unusual or non-recurring items. The limitations
of OIBITDA include: (i) it does not reflect our corporate expenditures or future requirements for capital expenditures or contractual
commitments; (ii) it does not reflect changes in, or cash requirements for, our working capital needs; (iii) it does not reflect income
tax payments we may be required to make; and (iv) it does not reflect the cash requirements necessary to service interest or principal
payments associated with indebtedness.
26
To
properly and prudently evaluate our business, we encourage you to review our consolidated financial statements included elsewhere in
this Annual Report on Form 10-K and the reconciliation to OIBITDA from net income (loss), the most directly comparable financial measure
presented in accordance with GAAP, set forth in the following table. All the items included in the reconciliation from net income (loss)
to OIBITDA are either (i) corporate costs or (ii) items that management does not consider in assessing our on-going operating performance.
In the case of the other items that management does not consider in assessing our on-going operating performance, management believes
that investors may find it useful to assess our operating performance if the measures are presented without these items because their
financial impact may not reflect on-going operating performance.
OIBITDA
calculation comparison for the years ended December 31, 2023 and 2022 are as follows:
December 31,
2023
2022
Operating income (loss)
$ (749 )
$ (906 )
Depreciation and amortization
18
32
Sales, general, and administrative
788
1,451
$ 57
$ 577
Operational
performance comparison for the years ended December 31, 2023 and 2022 are as follows:
December 31,
2023
2022
Revenue
$ 21,451
$ 25,725
Gross profit
$ 3,039
$ 3,494
OIBITDA
$ 57
$ 577
Net income (loss)
$ (740 )
$ (739 )
27
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.